Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 1-6.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Rathi N, Moghadas SM, Shivakumar PN, Therapeutic modelling of diabetes type 1, Type 1 Diabetes – Complications, Pathogenesis, and Alternative Treatments. In–Tech, 2011 Chapter 22, pp. 461–470.
Conway JM, Tuite AR, Fisman DN, Hupert N, Meza R, Davoudi B, English K, van den Driessche P, Brauer F, Ma J, Meyers LA, Smieja M, Greer AL, Skowronski DM, Buckeridge DL, Kwong JC, Wu J, Moghadas SM, Coombs D, Brunham RC, Pourbohloul B, Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything, BMC Public Health 2011, 11: 932.
Duvvuri VRSK, Moghadas SM, Guo H, Duvvuri B, Heffernan J, Fisman DN, Wu GE, Wu J, Highly conserved cross–reactive CD4+ T–cell HA–epitopes of seasonal and the 2009 pandemic influenza viruses, Influenza and Other Respiratory Viruses 2010, 4: 249–258.
Hansen E, Day T, Arino J, Wu J, Moghadas SM, Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks, Canadian Journal of Infectious Diseases and Medical Microbiology 2010, 21: e28–e63.
Tuite AR, Greer AL, Whelan M, Winter A–L, Yan P, Wu J, Moghadas SM, Buckeridge D, Pourbohloul B, Fisman DN, Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza, Canadian Medical Association Journal 2010, 182: 131–136.
Moghadas SM, Bowman CS, Röst G, Fisman DN, Wu J, Post–exposure prophylaxis during pandemic outbreaks, BMC Medicine 2009, 7:73.
Moghadas SM, Day T, Bauch C, Driedger SM, Brauer F, Greer AL, Yan P, Wu J, Pizzi NJ, Fisman DN, (Pan–InfORM Team) Modelling of pandemic influenza: a guide for the perplexed, Canadian Medical Association Journal 2009, 181: 171–173.
Arino J, Bowman CS, Moghadas SM, Antiviral resistance during pandemic influenza: implications for stockpiling and drug use. BMC Infectious Diseases 2009, 9: 1–12.
Moghadas SM, Bowman CS, Arino J, Competitive interference between influenza viral strains, Canadian Applied Mathematics Quarterly 2009, 17: 309–316.
Alexander ME, Dietrich SM, Hua Y, Moghadas SM, A comparative evaluation of modelling strategies for the effect of treatment and host interactions on the spread of drug resistance, Journal of Theoretical Biology 2009, 259: 253–263.